Brain calcification is associated with several neurodegenerative proteinopathies. Here, we report a new phenotype of intracranial calcification in transgenic P301L mice overexpressing 4 repeat tau. P301L mice (Thy1.2) of 3, 5, 9 and 18-25 months-of-age and age-matched non-transgenic littermates were assessed using in vivo/ex vivo magnetic resonance imaging (MRI) with a gradient recalled echo sequence and micro computed tomography (μCT). Susceptibility weighted images computed from the gradient recalled echo data revealed regional hypointensities in the hippocampus, cortex, caudate nucleus and thalamus of P301L mice, which in corresponding phase images indicated diamagnetic lesions. Concomitantly, µCT detected hyperdense lesions.
Introduction
Brain calcifications are detected in approximately 20% of aged individuals undergoing diagnostic neuroimaging, particularly in the pineal gland and choroid plexus [9, 15, 20, 29] .
Higher incidences of brain calcifications are found in patients with neurodegenerative diseases such as Alzheimer's disease (AD) [37, 38] , cerebral amyloid angiopathy [4] , frontotemporal dementia (FTD) [36] , Parkinson's disease and Down syndrome [68] . Calcified deposits in the human brain are also found distributed throughout the hippocampus and basal ganglia, and some are associated with cerebral vessels and cerebral amyloid angiopathy [7, 9, 15, 20, 57] . In patients with diffuse neurofibrillary tangles with calcification, pallidal calcification is the most prominent feature and is accompanied by frontotemporal atrophy, neurofibrillary tangle (NFT) deposition throughout the neocortex, without the occurrence of β -amyloid plaques [30] .
Symmetrical calcification of the basal ganglia is a key diagnostic criterion in patients with primary familial brain calcification [70] . The etiology of brain calcification is poorly understood, despite high prevalence of calcification in neurodegenerative disorders.
The discovery of tau mutations has facilitated the generation of several mouse models of human tauopathy e.g. P301S and P301L lines (transgenic for a human 4 repeat tau isoform) [6, [52] [53] [54] , which have become important tools to study the mechanisms of abnormal tau aggregation and deposition in FTD (4 repeat tau) [61] and AD (3 and 4 repeat tau) [25, 33, 41] . In the P301L 4 (Thy 1.2, pR5 line) [11, 18] , P301L (CaMKIIa) [23, 43, 62] and P301L (tetO) [14] mouse models, tau deposits begin forming before 3 months-of-age in neurons in the entorhinal cortex, hippocampus and later in the cortex, and amygdala; with neuroinflammation and impaired memory functions in hippocampus-and amygdala-dependent tasks manifesting at a later stage [49, 50, 67] . Brain atrophy and white matter changes indicating neurodegeneration were reported in P301L (CaMKIIa) mouse line around 9 months-of-age [16, 23, 43, 62] , which was driven by factors additional to human tau overexpression. However, unlike in human patients with tauopathies, brain calcifications have not been reported in transgenic mouse models of human disease.
Here, we report an early occurrence of intracranial calcifications in the P301L (Thy1.2) mouse model of tauopathy. Evidence is provided by high-field magnetic resonance imaging (MRI), micro computed tomography (μCT) which correspond to protein-containing nodules upon immunohistochemical staining. Parenchymal and vascular calcifications increase with age and are associated with intra-neuronal phosphorylated-tau deposition in the hippocampus. The P301L mouse line may be a suitable animal model to study the role of brain calcification in human tauopathy. 
Materials and methods

Animals
Magnetic resonance imaging
MRI was performed as described previously [27, 44] . To reduce field inhomogeneities, global 1 st -order followed by fieldmap-based local shimming on the mouse brain was performed. Phase maps and SW images were generated using Paravision software 6.0.1 as described previously [27] .
SW images were compared with their phase image counterparts to ensure that the signals were due to a diamagnetic signal (i.e. presence of calcifications). The numbers of suspected calcified spots in a panel of an anatomical region (hippocampus, thalamus, caudate nucleus, midbrain and cortex etc.) were quantified using the ex vivo datasets acquired at 9.4T. The Allen mouse brain atlas was used for anatomical reference [24] .
µCT After the ex vivo MRI, the mouse heads were scanned in 0.1 M PBS (pH 7.4) in a microCT 40
(Scanco Medical AG, Brüttisellen, Switzerland) operated at 45 kVp, 177 µA intensity, an integration of 200 ms and two-fold frame averaging. From 1000 projection images, 3D datasets with isotropic voxels of 8µm were reconstructed and converted to DICOM format using the scanner software. DICOM files were exported and analyzed using ITK SNAP [73] .
Histochemistry & Immunohistochemistry
The 4 % paraformaldehyde fixed mouse brains were cut sagittally into two hemispheres. One hemisphere was cut into 60 μm coronal sections using a vibratome (Leica VT1000S, Germany)
for fluorescence immunohistochemistry. The protocol used for fluorescence immunohistochemistry was described previously [43, 46, 75] . Primary antibodies used for immunofluorescence staining are listed in Supplementary table 2 . All fluorescently-labelled (Alexa 488, Cy3, DyLight 649) secondary antibodies (suitable for multiple labelling) were hosted in donkey (anti-rabbit, anti-rat, anti-mouse and anti-goat, Jackson Immunoresearch, UK).
Brain sections were pre-treated with mouse-on-mouse kit (Vector Laboratories, USA) to quench the endogenous IgG and subsequently incubated with primary and secondary antibodies. Sigma-Aldrich, Switzerland) and hydrogen peroxide (Sigma-Aldrich, Switzerland).
Counterstaining was performed using Hematoxylin. Stained paraffin sections were scanned using a NanoZoomer HT (Hamamatsu Photonics, Japan) using a 40× objective. Images were analyzed using Digital Image Hub software (SlidePath) and Adobe Illustrator CS6 (Adobe, USA).
Hematoxylin & Eosin stained whole sagittal mouse brain slices were imaged at 20× magnification using Pannoramic 250 (3D HISTECH, Hungary). The images were analyzed using CaseViewer (3D HISTECH, Hungary) and ImageJ (NIH, USA).
Statistics
Statistical analysis was performed using GraphPad Prism 7.0 (GraphPad Software, U.S.A). 9 D'Agostino & Person normality test was used for assessing the normal distribution of the data.
One-way ANOVA with Turkey's post-hoc analysis was used for group comparison. The difference between groups was considered significant (*) at p value < 0.05. All error bars in the figures are expressed as standard deviation.
Results
Phase imaging detects the presence of diamagnetic lesions in P301L mouse brain
Gradient recalled echo data of P301L mice and non-transgenic littermates were collected ( Fig. 1-3 ). We observed hypointensities in the SW images ( Fig. 1-3 ). Corresponding phase images showed positive phase shifts (hyperintensities) in corresponding locations, indicating the diamagnetic nature of lesions ( Fig. 1-3) . The magnetic susceptibility [55] and appearance of the lesions indicated the presence of calcified deposits. Blood degradation products such as hemosiderin are paramagnetic and would induce opposite signal shifts. Hypointensities in the SW images on reconstructed data from in vivo MRI at 7T ( Fig. 1 ) correspond well to that from ex vivo MRI at 9.4T ( Fig. 3) . However, boundaries of lesions were sharper in the 9.4T compared to 7T images due to the difference in field strengths and scan parameters.
Hypointensities/positive phase shifts in P301L mice were detected in all age groups by using in vivo and ex vivo SWI/phase image, prominently in the hippocampus, but also in the thalamus, caudate nucleus, choroid plexus and midbrain ( Fig. 1, 2, 3) . In aged non-transgenic littermates such lesions were only observed in the choroid plexus (e.g. positive phase shifts in the 4 th ventricle, which appeared as a cohesive structure) ( Fig. 2a-c) . In the other brain regions hyperintenities/positive phase shifts on SW/phase images appeared as ovoid (Fig. 3b , c, f, g), 1 0 elongated (Fig. 3e, i) lesions, and nests ( Fig. 3d, h) . D'Agostino & Person normality test results in p = 0.0648, indicating passing the normality test. The number of SW/phase diamagnetic deposits increased with age in the hippocampus, but not the other brain structures (18 months-old vs 3 months-old, p <0.0001; vs 5 months-old, p <0.0001; and vs 9 months-old, p <0.0001, Fig.   3j ). No statistically significant difference was observed between male and female mice within age groups (Fig. 3k) .
µCT detects hyperdense lesions in the brain of P301L mice
To further assess cerebral lesions in the brain of P301L mice, ex vivo μCT scans were performed on the same brain samples. μCT images showed hyperdense lesions in 5, 9-and 18+ months-old P301L mice. The higher X-ray density in these areas indicates the presence of material of higher atomic number than soft tissue [56] . Hyperdense lesions were seen in regions that correspond to the hippocampus, deep brain regions, cerebellum, and cortex when compared to SW and phase MR images in the same mice ( Fig. 4a-d) . Hyperdense structures in the choroid plexus of the third ventricle were observed in the μ CT images of P301L mouse brains and also in aged controls. However, fewer lesions were observed using μ CT compared to MRI. Nevertheless, this adds further evidence for the presence of intracranial calcification in P301L mice.
Vascular bone protein-containing nodules in the thalamus of P301L mice
As a next step, we used histochemistry and immunohistochemistry to investigate the nature of the imaging lesions in different brain regions of P301L mice. To this end, we used immunohistochemical staining with antibodies against bone proteins deposited in brain calcifications [15, 75] . In the thalamus, osteocalcin-and osteopontin-positive nodules were 1 1 associated with blood vessels, in the absence of phosphorylated-tau (AT8 and AT100) staining ( Fig. 5a-h) . Interestingly, similar to previous reports [42, 74] , we detect amyloid-precursor protein (APP), a marker for damaged neurons [58] , deposition in vascular nodules containing bone proteins ( Fig. 5i-l) . These nodules were visualized using hematoxylin and eosin staining, a standard histological stain, indicating the basophilic nature of these structures (Fig. 5m) . In addition, vascular calcification in the thalamus elicits a strong glial reactivity (Fig. 5n, o) , reminiscent to changes described in a mouse models of primary familial brain calcification [26, 42, 75] .
We performed histology on sagittal brain sections of P301L mouse and non-transgenic littermate brains to verify the presence of other neuropathology in the brain of P301L mice. Alcian blue, Periodic acid-Schiff, and Hematoxylin & Eosin staining showed no pathological abnormalities or infarction in the mouse brain P301L mice at 18 month-of-age (SFig. 1). Furthermore, Prussian blue staining demonstrated that the imaging pattern in the P301L mouse brains were not cerebral microbleeds (SFig. 1c, d ).
Vascular and intracellular bone protein-containing nodules s in the hippocampus
The hippocampus of P301L mice was found to be a prominent site of imaging pattern indicative of tissue calcification (Fig. 3 ). Immunohistochemistry using antibodies against bone proteins confirmed their presence in deposits in the hippocampus (Fig. 6a-p) , which were vascular ( Fig.   6e-h) and parenchymal ( Fig. 6i-l) . In contrast to the thalamus, we observed in the hippocampus of P301L mice intracellular staining of osteocalcin which was co-localizing with phosphorylatedtau detected using antibodies AT8 and AT100 ( Fig. 6i-l) . 1 2 
Discussion
In this study, we observed imaging pattern on high-resolution μ CT and gradient recalled echo MRI, indicative of intracranial calcification, in brains of P301L mice. Immunohistochemistry revealed that these bone protein-containing lesions were either vessel-associated or intracellular and co-localizing with phosphorylated-tau.
CT is considered the non-invasive gold standard for the identification of intracranial calcification [3] , with hyperdensity threshold >100 Hounsfield units [5] . In comparison, in conventional T 1 -, [55] . In our study, all hypointense inclusions on SW images of P301L mouse brain were diamagnetic, indicating the presence of intracranial calcifications ( Fig. 1-3) . Negativity for Prussian blue staining indicated the absence of cerebral microbleeds and other iron deposition in the brain of P301L mice (SFig. 1c, d) . Immunohistochemistry revealed that lesions are positive for bone proteins, thus indicating that the characteristic radiological pattern corresponds to markers of calcified tissue (Fig. 5, 6) . Studies using clinical brain imaging data suggest that the diagnostic accuracy of SWI outperformed conventional MRI and CT in detecting brain calcifications [1, 32, 71, 72, 76] , although the diagnostic accuracy of different methods might depend on disease indication, MRI parameters and field strengths used. 1 3 In non-transgenic littermates, imaging abnormalities were found confined to the choroid plexus.
While this has been reported to occur in aged individuals [20] it has so far not been reported as a phenotype in aged mice. In P301L mice we observed high inter-individual variations in hypointensities on SW images in all anatomical regions (Fig. 2g) , similarly to previous studies in patients with familial brain calcification and mouse models thereof [26, 75] .
The etiology of most forms of brain calcifications are unknown, but they may occur under several pathophysiological conditions, including inflammation, metabolic, infectious and genetic syndromes and after exposure to toxins or radiotherapy [10, 12, 35] . Loss-of-function mutations in genes involved in familial forms of diseases presenting with brain calcification have been associated with disturbance in phosphate homeostasis and the dysfunction of the blood-brain barrier [34] . This was supported by the finding of mutations in tight junction components in other genetic diseases with intracranial calcifications [40, 45] . Moreover, studies using hypomorphs of platelet derived growth factor subunit B suggested a connection between bloodbrain barrier impairment and brain calcification [26] , however, later studies did not find a causal evidence [65, 66] . Interestingly, blood-brain barrier breakdown has been reported in P301L tauopathy mice, with erythrocyte and leukocyte infiltration occurring before accumulation of hyperphosphorylated tau [4] , thus it would be of interest for future studies to investigate if bloodbrain barrier impairment plays a role in the manifestation of brain calcification in this setting.
The genetic cause of basal ganglia calcification with dementia and bone cysts has been linked with triggering receptor expressed on myeloid cells 2 (TREM2) mutation [28] , and TYRO protein tyrosine kinase binding protein (TYROBP, formerly DAP12) [48] on chromosome 19. 1 4 Mutations in TREM2 presenting as a FTD-like syndrome without bone involvement were later also reported [8, 17, 21, 22] . TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in the tauopathy mouse model [2] , suggesting microglial activation may also play a role in the tau pathology. We observed strong glial reactivity towards calcified nodules in the thalamus of the P301L mice (Fig. 5n, o) . Reactive astrocytes and microglia surrounded calcified deposits and it will be interesting to study whether glia cells control the progression of the pathology as in hereditary brain calcification [74] . Further studies will need to elucidate if these calcifications in P301L are also TREM2 dependent and if there will be differences in susceptibility between the thalamic and hippocampal ones.
Intracranial calcification may also be linked to tauopathy. Studies demonstrated hippocampal calcification in the brain of patients with AD and FTD using CT and histopathology [51] . This is in line with our study where hypointensities were most abundant in the hippocampus, increasing in an age-related manner (Fig. 3j) . Furthermore, we found co-localization of tau (AT8, AT100)
with osteocalcin in hippocampal neurons, an earliest brain region affected in AD and FTD (Fig.   6d, l) . In P301L mice, tau accumulation is prominent in the hippocampus, amygdala, and cortical regions, but sparse in the brain stem, thalamus, and caudate nucleus [18, 69] . The tau distribution was not matched regionally with the hypointensity pattern seen on MR imaging at whole brain level (Fig 1, 2, 3) . The susceptibility to develop calcification may thus depend on a number of other factors in addition to human tau overexpression, such as the biochemical, and genetic properties. The individual and combined contribution of these factors to the formation of brain calcification needs further research [39] . Given the non-invasive nature of the imaging read-outs, longitudinal studies would be informative with respect to individual changes in calcium load and 1 5 can be combined with other read-outs (e.g. perfusion measurement, elastography etc.).
We observed APP and osteopontin accumulation in the thalamic nodules in P301L mice. APP is a marker for damaged neurons [58] and osteopontin is a bone protein upregulated in damaged brain [59] . Both APP [58] and osteopontin [15, 75] are reported in the extracellular matrix of calcified tissue. The presence of APP could be an indication of damaged neurons in the area [42] .
Here, we observed that they accumulate in the thalamic calcifications in P301L mice similar to other reports about brain calcifications, further supporting that these nodules are indeed calcified.
As the antibody for APP binds to amino acids 85-99 of the C99 fragment of APP, which might bind to amyloid-beta deposits and APP C-terminal fragment C99 located in dystrophic neurites.
Once manifested, brain calcification can affect brain function by evoking expression of neurotoxic astrocyte markers, interfering with neuronal circuitry and/or glucose metabolism [32, 60, 75] . However, the functional contribution of brain calcification to neuropsychiatric symptoms in various brain disorders is still debated [13, 47] . Patients with primary familial brain calcification often present with impaired movement (parkinsonism and dystonia), but also cognitive impairment and psychiatric manifestations, including schizophrenia-like symptoms, mood disorders, or obsessive-compulsive disorder [13] . Patients with diffuse neurofibrillary tangles with calcification including early but progressive memory and verbal disturbances, followed by psychiatric symptoms. While the P301L strain shows impaired memory functions in hippocampus-and amygdala-dependent tasks [49, 50] , future studies need to disentangle the potential contributions of tauopathy-related brain calcification to functional deficits. 1 6
Conclusions
We described a new brain phenotype of P301L mice, characterized by imaging patterns of intracranial calcification. The study further suggests a potential link between tau deposition and tissue calcification, where the underlying pathophysiology and functional consequences need to be further investigated. The P301L mouse strain therefore may be a suitable model to study the pathogenesis and pathophysiology of brain calcifications in FTD and AD, and other tauopathies.
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